Analyst
Morgan Stanley
Equibles does not estimate personal net worth.
Callum Tishmarsh is recorded as Analyst at Morgan Stanley. Callum Tishmarsh has spoken on 5 earnings calls and 8 other investor events across 10 companies, most recently for Thermo Fisher Scientific Inc. on September 15, 2026. Those appearances were for GRAIL, Inc. (GRAL), Natera, Inc. (NTRA), Tempus AI, Inc. (TEM), Thermo Fisher Scientific Inc. (TMO), Guardant Health, Inc. (GH) and 5 other companies. The companies whose calls Callum Tishmarsh spoke on are classified in the Healthcare sector.
“Day two of Morgan Stanley's Global Healthcare Conference. I'm Callum Tishmarsh. I run the Life Science Tools and Diagnostics team. Really pleased today to be joined by Mark Kasper, Thermo's CEO.”
“Really pleased today to be joined by the team at Garden Health. We have Amiradi Talisaz, co-CEO, and Mike Bell, CFO. Thank you both for being here. Thanks for having us.”
“I run the Life Sciences team here at MS. Really pleased today to be joined by the team from Stepanado. We have Marco Del Lago, CFO, and Lisa Miles, Chief Communications and Investor Relations Officer.”
“Thank you all for joining us today, joined by Eric Fung, Chief Medical Officer at GRAIL, for a fireside chat discussion. But just before we get started, for all disclosures relating to this presentation, please see morganstanley.com forward slash research disclosures.”
“Okay, I know we're a couple of minutes away, but I think we can get started, given there's a lot to cover. I'm Callum Tishma, the Life Sciences Analyst here at Morgan Stanley.”
Morgan Stanley
Analyst
Transcript header (unverified)
GRAL
Diagnostics & Research · Healthcare
NTRA
Diagnostics & Research · Healthcare
TEM
Health Information Services · Healthcare
Medical Instruments & Supplies · Healthcare
Medical Instruments & Supplies · Healthcare
